{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T04:36:56Z","timestamp":1761885416251,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.acuroe.2022.05.001","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T08:14:09Z","timestamp":1655453649000},"page":"423-430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The probability of residual tumor detection in the second transurethral resection of pT1 urothelial bladder cancer according to the risk factors"],"prefix":"10.1016","volume":"46","author":[{"given":"M.","family":"Culpan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Kazan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Cansu","family":"Acar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Iplikci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Atis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Yildirim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.acuroe.2022.05.001_bib0005","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.acuroe.2022.05.001_bib0010","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","article-title":"Platinum priority \u2013 review \u2013 bladder cancer epidemiology and risk factors of urothelial bladder cancer","volume":"63","author":"Burger","year":"2013","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.acuroe.2022.05.001_bib0015","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.acuroe.2022.05.001_bib0020","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1464-410x.2001.02306.x","article-title":"A systematic review of intravesical bacillus Calmette-Gu\u00e9rin plus transurethral resection vs transurethral resection alone in Ta and T1 bladder cancer","volume":"88","author":"Shelley","year":"2001","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.acuroe.2022.05.001_bib0025","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.eururo.2018.02.014","article-title":"Repeat transurethral resection in non\u2013muscle-invasive bladder cancer: a systematic review","volume":"73","author":"Cumberbatch","year":"2018","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.acuroe.2022.05.001_bib0030","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.eururo.2010.03.007","article-title":"Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial","volume":"58","author":"Divrik","year":"2010","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.acuroe.2022.05.001_bib0035","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2019.08.016","article-title":"European association of urology guidelines on non-muscle-invasive bladder cancer (TaT1 and Carcinoma In Situ) - 2019 update","volume":"76","author":"Babjuk","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuroe.2022.05.001_bib0040","unstructured":"Chang SS, Boorjian SA, Chou R, Clark PE, Daneshmand S, Konety BR, et al. American Urological Association (AUA)\/Society of Urologic Oncology (SUO) Guideline DIAGNOSIS AND TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER: AUA\/SUO GUIDELINE 2016, Amended 2020. 2020;(May):1-45."},{"issue":"1","key":"10.1016\/j.acuroe.2022.05.001_bib0045","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/bju.13354","article-title":"The impact of re-TUR on clinical outcomes in a large multi-centre cohort of T1-HG\/G3 patients treated with BCG","volume":"118","author":"Gontero","year":"2016","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.acuroe.2022.05.001_bib0050","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.acuro.2014.01.001","article-title":"Second transurethral resection and prognosis of high-grade non-muscle invasive bladder cancer in patients not receiving Bacillus Calmette-Gu\u00e9rin","volume":"38","author":"Angulo","year":"2014","journal-title":"Actas Urol Esp (English Edition)"},{"issue":"3","key":"10.1016\/j.acuroe.2022.05.001_bib0055","first-page":"252","article-title":"Identification of potential prognostic factors for absence of residual disease in the second resection of T1 bladder cancer","volume":"72","author":"Czech","year":"2019","journal-title":"Cent Eur J Urol"},{"issue":"4","key":"10.1016\/j.acuroe.2022.05.001_bib0060","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4103\/0974-7796.140990","article-title":"Predictive factors for residual tumor and tumor upstaging on relook transurethral resection of bladder tumor in non-muscle invasive bladder cancer","volume":"6","author":"Gill","year":"2014","journal-title":"Urol Ann"},{"issue":"2","key":"10.1016\/j.acuroe.2022.05.001_bib0065","first-page":"152","article-title":"Second transurethral resection of bladder tumor: is it necessary in all T1 and\/or high-grade tumors?","volume":"16","author":"Ayati","year":"2019","journal-title":"Urol J"},{"issue":"2","key":"10.1016\/j.acuroe.2022.05.001_bib0070","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10147-016-1048-z","article-title":"Clinical outcomes of second transurethral resection in non-muscle invasive high-grade bladder cancer: a retrospective, multi-institutional, collaborative study","volume":"22","author":"Kamiya","year":"2017","journal-title":"Int J Clin Oncol"},{"issue":"8","key":"10.1016\/j.acuroe.2022.05.001_bib0075","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.21873\/anticanres.13598","article-title":"Predictive factors for residual cancer in second transurethral resection for non-muscle-invasive bladder cancer","volume":"39","author":"Akitake","year":"2019","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.acuroe.2022.05.001_bib0080","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.urolonc.2019.08.010","article-title":"Predictive factors of the absence of residual disease at repeated transurethral resection of the bladder. Is there a possibility to avoid it in well-selected patients?","volume":"38","author":"Soria","year":"2020","journal-title":"Urol Oncol"},{"issue":"4","key":"10.1016\/j.acuroe.2022.05.001_bib0085","doi-asserted-by":"crossref","first-page":"272","DOI":"10.4081\/aiua.2017.4.272","article-title":"Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience","volume":"89","author":"Giulianelli","year":"2017","journal-title":"Arch Ital Urol Androl"},{"issue":"1","key":"10.1016\/j.acuroe.2022.05.001_bib0090","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/MOU.0000000000000697","article-title":"En bloc resection for nonmuscle invasive bladder cancer: review of the recent literature","volume":"30","author":"Mori","year":"2020","journal-title":"Curr Opin Urol"},{"issue":"1","key":"10.1016\/j.acuroe.2022.05.001_bib0095","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.eururo.2019.09.029","article-title":"Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and its clinical impact on the management of high-risk non\u2013muscle-invasive bladder cancer patients candidate for repeated transurethral resection","volume":"77","author":"Del Giudice","year":"2020","journal-title":"Eur Urol"}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578622000452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578622000452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:15:49Z","timestamp":1761880549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173578622000452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S2173578622000452"],"URL":"https:\/\/doi.org\/10.1016\/j.acuroe.2022.05.001","relation":{},"ISSN":["2173-5786"],"issn-type":[{"type":"print","value":"2173-5786"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The probability of residual tumor detection in the second transurethral resection of pT1 urothelial bladder cancer according to the risk factors","name":"articletitle","label":"Article Title"},{"value":"Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acuroe.2022.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 AEU. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}